13.07.2015 Views

Bavarian Biotech Report 2011/2012 (7MB) - Bio M

Bavarian Biotech Report 2011/2012 (7MB) - Bio M

Bavarian Biotech Report 2011/2012 (7MB) - Bio M

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Nuvisan GmbHCROKeywords: Oncology, Small Molecules, Peptide/Protein, Pharmacokinetics,PCR, ELISA / EIA, Clinical ResearchNuvisan Pharma Services is a global provider of product development andsupport services to the pharmaceutical, biotechnology and medical deviceindustries. We deliver services ranging from a single test to fully integrateddrug development programs.Together with Focus we are pleased to offer our sponsors the completespectrum of drug development services and assist the sponsor in bringingsafe and effective pharmaceutical products to market.Contact:Dr. Karl MichaelisWegenerstr. 13D-89231 Neu-UlmPhone: +49 (0) 731 9840-0Fax: +49 (0) 731 9840-280E-Mail: karl.michaelis@nuvisan.comInternet: www.nuvisan.comOmegametrix GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSProf. W.S. Harris, Stanford University – USA, and Prof. C. von Schacky,University of Munich, invented and defined the HS-Omega-3 Index in 2004.Then, in 2006 Schacky founded Omegametrix GmbH, as a Laboratory, todeal with the ever growing number of research projects, applications andsamples. Initially proposed as a risk factor for sudden cardiac death, it nowindicates cardiovascular risk as well. First studies have shown its associationto life expectancy in general. Other applications, still in development,range from psychiatric diseases to pregnancy and lactation.Contact:Adrian PassowAm Klopferspitz 19D-82152 MartinsriedPhone: +49 (0) 89 55063007Fax: +49 (0) 89 55063008E-Mail: info@omegametrix.euInternet:www.omegametrix.euOncoLead GmbH & Co. KGBIOTECH THERAPEUTICS & DIAGNOSTICSKeywords: Drug Development, Clinical Diagnostics, Tissue Engineering / CellCulture, Cell Therapy, OncologyOncoLead offers cellular screens designed to accelerate the decision makingprocess for the development of anticancer drugs. Its information driven cellpanel screen is to help scientists from all sectors to discover and developnovel and innovative anticancer medicines faster.Contact:Dr. Igor IvanovFraunhoferstr. 20D-82152 MartinsriedPhone: +49 (0) 89 38012215-0Fax: +49 (0) 89 38012215-9E-Mail: request4more@oncolead.comInternet: www.oncolead.com95

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!